Back to search

Netherlands· NL-3260b42ce118

Amikacine Eureco-Pharma 500 mg/2 ml oplossing voor injectie

A amikacin product containing amikacine sulfaat, registered in Netherlands by Eureco-Pharma B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC J01GB06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAmikacine Eureco-Pharma 500 mg/2 ml o…ATCJ01GB06REGISTER NO.NL-3260b42ce118PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Amikacin is registered in 15 of 19 countries.

Countries holding a registration under ATC J01GB06 (amikacin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Amikacin · ATC J01GB06

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
AMIKACINE SULFAAT
Manufacturer
Eureco-Pharma B.V.
Country
Netherlands (NL)
ATC code
J01GB06
ATC class
Amikacin
Defined daily dose
0.59 g, Inhal
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    128938//22424

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

253 interactions on record for amikacin.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Amikacin · interactions on record

253 records

  • 50 severe
  • 133 moderate
  • 2 minor
  • 68 info

Most severe, free to view

  • Magnesium sulfateA06AD04severe
  • MannitolA06AD16severe
  • Polymyxin BA07AA05severe
  • Magnesium sulfateA12CC02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Amikacin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amikacin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Amikacin B. Braun
  • Belgium · Amikacine B. Braun, Amikacine Fresenius Kabi
  • Bulgaria · Amikacin Kabi, Амикацин Б. Браун
  • Cyprus · Amika-Synto, Amikacin Vioser
  • Czechia · Amikacin B. Braun, Amikacin Fresenius Kabi
  • Germany · Amikacin B. Braun, Amikacin Eberth
  • Denmark · Amikacin Afortas, Amikacin Macure
  • Estonia · Amikacin B. Braun
  • Spain · Amicacina, Amicacina B. Braun
  • Finland · Amikacin Afortas, Amikacin Macure
  • France · Amikacine B. Braun, Amikacine Kabi
  • United Kingdom (Northern Ireland) · Amikacin Demo Pharma Uk, Amikacin Galvany Pharma
  • Greece · Amicasil, Amikacin Anfarm
  • Croatia · Amikacin Zentiva
  • Hungary · Amikacin Anfarm, Amikacin B. Braun
  • Ireland · Amikacin, Amikacin Athlone Pharmaceuticals
  • Iceland · Arikayce Liposomal
  • Italy · Amicasil, Amikacina B. Braun
  • Liechtenstein · Arikayce Liposomal
  • Lithuania · Biodacyna
  • Luxembourg · Amikacin B. Braun, Amukin
  • Latvia · Amikacin B.Braun
  • Malta · Amikacin Tillomed Laboratories, Uzix
  • Norway · Amikacin Afortas, Amikacin Macure
  • Poland · Amikacin B. Braun, Amikacin Kabi,
  • Portugal · Amicacina Hikma, Amicacina Kabi
  • Romania · Amikacin Noridem, Amikacină Atb
  • Sweden · Amikacin Afortas, Amikacin Fresenius Kabi
  • Slovenia · Amikacin Kabi
  • Slovakia · Amikacin B. Braun, Amikacin Fresenius Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9424fae5-501b-40a5-b042-0fe77cdff51b
GET /v1/drugs/9424fae5-501b-40a5-b042-0fe77cdff51b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intramusculair gebruik, Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h22424_smpc.pdf",
  "strength": null,
  "atc_label": "Amikacin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128938",
  "excipients": [
    "NATRIUMMETABISULFIET (E 223)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER VOOR INJECTIE",
    "ZWAVELZUUR (E 513)"
  ],
  "substances": [
    "AMIKACINE SULFAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128938.pdf",
  "authorised_at": "2022/09/22",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "128938//22424",
  "additional_monitoring": "N"
}

See everything about amikacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.